Robotics

Robotic interface masters a soft touch

The perception of softness can be taken for granted, but it plays a crucial role in many actions and interactions—from judging the ripeness of an avocado to conducting a medical exam, or holding the hand of a loved one. ...

Consumer & Gadgets

Robot dogs and flyng cars: mobile gadget highlights

Tech companies showcased countless connected gadgets at the world's biggest wireless telecom fair, the four-day Mobile World Congress in Barcelona, which wraps up on Thursday.

Machine learning & AI

Diversifying data to beat bias

AI holds the potential to revolutionize health care, but it also brings with it a significant challenge: bias. For instance, a dermatologist might use an AI-driven system to help identify suspicious moles. But what if the ...

Consumer & Gadgets

Women's health on show, a little, at CES

Among the more than 3,500 booths at the Consumer Electronics Show (CES) in Las Vegas, only a few focus exclusively on women's health, including a cervical cancer screening device and a wristband to anticipate hot flushes.

Business

Tech giants form AI group focused on ensuring safety

Four US leaders in artificial intelligence (AI) announced Wednesday the formation of an industry group devoted to addressing risks that cutting edge versions of the technology may pose.

page 1 from 6

Cancer

Cancer (medical term: malignant neoplasm) is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer may affect people at all ages, even fetuses, but the risk for most varieties increases with age. Cancer causes about 13% of all human deaths. According to the American Cancer Society, 7.6 million people died from cancer in the world during 2007. Cancers can affect all animals.

Nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may be randomly acquired through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers are usually affected by complex interactions between carcinogens and the host's genome. New aspects of the genetics of cancer pathogenesis, such as DNA methylation, and microRNAs are increasingly recognized as important.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Diagnosis usually requires the histologic examination of a tissue biopsy specimen by a pathologist, although the initial indication of malignancy can be symptoms or radiographic imaging abnormalities. Most cancers can be treated and some cured, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments.

This text uses material from Wikipedia, licensed under CC BY-SA